Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Spontaneous myogenic oscillations will be studied under general anesthesia using finger photoplethysmography. This pilot study will explore potential physiological conditions that will effect the amplitude and/or frequency of myogenic oscillations.
This is a single center, nonrandomized, nonblinded, interventional clinical pilot research study that plans to enroll 40 patients.
Study will be conducted while subjects are under general anesthesia.
Myogenic oscillations will be measured using finger photoplethysmography. Changes in the amplitude and/or frequency of these oscillations will be analyzed in response to the interventions. Arterial blood pressure will be recorded to verify the efficacy of the interventions.
Six different interventions that will either lower or increase blood pressure will be applied to the subjects. Each subject will receive 1 or 2 of the six interventions. Each of the 6 interventions will be applied to 8 subject.
The interventions that the subject will not be randomized. They will be determined by the subjects blood pressure immediately before the intervention to guarantee that the blood pressure manipulations are within a safe range.
Data will be analyzed offline using Matlab.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Phenylephrine | Experimental | Phenylephrine (100 ug/ml) infusion will be used to increase blood pressure by 20 mmHg |
|
| Dexmedetomidine | Experimental | Dexmedetomidine infusion will be used to increase blood pressure by 20 mmHg |
|
| Clevidipine | Experimental | Clevidipine infusion will be used to increase blood pressure by 20 mmHg |
|
| Calcium Chloride | Experimental | Calcium Chloride will be administered to increase blood pressure and to increase blood calcium concentration |
|
| tetanic stimulus | Experimental | A 5 second 70 mA tetanic stimulus will be used to increase peripheral vascular tone |
|
| Increased venous pressure | Experimental |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Phenylephrine | Drug | blood pressure will be increased or decreased by using one of six interventions: phenylephrine (alpha-1 agonist), dexmedetomidine (alpha-2 agonist), clevidipine (Ca channel blocker, CaCl, tetanic stimulus and increase in venous pressure |
| Measure | Description | Time Frame |
|---|---|---|
| myogenic oscillations | change in amplitude and/of frequency of myogenic oscillations | up to 5 minutes |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pekka Talke, MD | University of California, San Francisco | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of California San Francisco | San Francisco | California | 94122 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D010656 | Phenylephrine |
| D020927 | Dexmedetomidine |
| C118563 | clevidipine |
| D002122 | Calcium Chloride |
| ID | Term |
|---|---|
| D004983 | Ethanolamines |
| D000605 | Amino Alcohols |
| D000438 | Alcohols |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A 5 minute inflation of a noninvasive blood pressure cuff to 30 mmHg to increase venous pressure in the arm.
|
|
| Dexmedetomidine | Drug | blood pressure will be increased or decreased by using one of six interventions: phenylephrine (alpha-1 agonist), dexmedetomidine (alpha-2 agonist), clevidipine (Ca |
|
|
| Clevidipine | Drug | blood pressure will be increased or decreased by using one of six interventions: phenylephrine (alpha-1 agonist), dexmedetomidine (alpha-2 agonist), clevidipine (Ca |
|
|
| tetanic stimulus | Other | A 5 second 70 mA tetanic stimulus will be applied to elicit peripheral vasoconstriction (stress response) |
|
| Increased venous pressure | Other | A 5 minute inflation of a noninvasive blood pressure cuff to 30 mmHg to increase venous pressure in the arm with the pulse oximeter probes. |
|
| Calcium Chloride | Drug | CaCl will be administered to increase blood pressure and plasma calcium concentration |
|
| D000588 |
| Amines |
| D007093 | Imidazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D017610 | Calcium Compounds |
| D007287 | Inorganic Chemicals |
| D002712 | Chlorides |
| D006851 | Hydrochloric Acid |
| D017606 | Chlorine Compounds |